CCL2 and polycystic ovary syndrome: These findings suggest that the improvement of ovarian polycystic morphology in polycystic ovary syndrome (PCOS) mice following BCE treatment may be associated with the reduction of M1 infiltration, decreased expression of monocyte chemoattractant protein-1 (MCP-1), and increased infiltration of M2 macrophages in the ovaries [86].